Netanyahu Reveals Prostate Cancer Treatment During Iran War Period

Benjamin Netanyahu revealed he was treated for early-stage prostate cancer in late 2024, after undergoing surgery and radiation therapy following a diagnosis made public in January 2025. The Israeli prime minister disclosed the timeline in a televised interview on March 18, 2025, stating that medical intervention began after December 2024 and concluded before the escalation of hostilities with Iran in April 2025. Netanyahu said the cancer was detected during a routine screening in November 2024, leading to a prostatectomy at Sheba Medical Center in Tel HaShomer. He subsequently completed a course of external beam radiation therapy in February 2025. His medical team confirmed the malignancy was localized and classified as Gleason score 3+4, indicating intermediate risk but treatable with curative intent. The disclosure came amid heightened regional tensions, including Israel’s military operations in Gaza and indirect confrontations with Iranian-backed forces. Netanyahu emphasized that his treatment did not interfere with governmental duties, noting he continued to participate in security briefings and cabinet meetings throughout the process, albeit with adjusted scheduling to accommodate medical appointments. He declined to specify whether the diagnosis was concealed from senior officials or international partners during the period, stating only that personal health matters are managed privately unless they impact capacity to serve. No evidence has emerged suggesting any disruption to decision-making during the treatment window. Netanyahu’s physicians released a brief statement through the Prime Minister’s Office on March 19, 2025, confirming he remains under active surveillance with PSA levels within normal range and no evidence of recurrence. They advised continued monitoring every three months for the next two years. The revelation has prompted discussion within Israel’s Knesset about the transparency of leaders’ health disclosures, though no formal legislative proposals have been introduced. Opposition leaders have called for clearer protocols, whereas coalition members defended the prime minister’s right to medical privacy. Netanyahu has not announced any changes to his official schedule or upcoming diplomatic engagements, including a planned visit to Washington in late April 2025 to meet with U.S. Officials regarding regional security and arms transfers. His office stated the trip remains on schedule unless medical advice dictates otherwise.